Hepa Merz contributes to the development of insulin and growth hormone.

HepaMerz

Hepa Merz as a scientifically proven therapy is indicated in following liver disorders:

  • Acute Hepatitis (Viral, non-viral, drug induced)
  • Chronic Hepatitis (with or without hyperammonaemia)
  • Cirrhosis of Liver
  • Fatty Liver with hyperammonaemia
  • Hepatic Encephalopathy
  • As an adjuvant therapy with all hepatotoxic drugs

Untitled-2

Hepa Merz contributes to the development of insulin and growth hormone. It improves the detoxication function of the liver, lowers elevated levels of ammonia in plasma.

It also improves protein metabolism in diseases requiring parenteral nutrition.

Indications:

Acute and chronic liver disease, accompanied by hyperammonemia, hepatic encephalopathy (latent and severe), including in the complex treatment of disorders of consciousness (coma or precoma) parenteral nutrition in patients with protein deficiency (as a corrective supplement).

How it works:

Hepa-Merz is a stable combination of two important endogenous Amino Acids, L-Ornithine and L-Aspartate. After administration it quickly breaks down into L-Ornithine and L-Aspartate. L-Ornithine being a substrate of urea cycle, converts toxic ammonia into non-toxic urea which is eliminated via kidneys, helping the diseased liver to carry out its normal function smoothly (detoxification). The process lowers the elevated level of ammonia in blood (hyperammonaemia) which is a common problem in most of the liver diseases.

L-Aspartate is an essential component of citric acid cycle which liberates energy (ATP), and thus helps in regeneration of damaged liver cells.

Dosage:

use 1 pack a day bed time